{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T18:59:43Z","timestamp":1782413983857,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T00:00:00Z","timestamp":1461888000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s00345-016-1835-1","type":"journal-article","created":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T15:36:50Z","timestamp":1461944210000},"page":"113-120","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Prognostic role of decreased E-cadherin expression in patients with upper tract urothelial carcinoma: a multi-institutional study"],"prefix":"10.1007","volume":"35","author":[{"given":"Ricardo L.","family":"Favaretto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atessa","family":"Bahadori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Haitel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Grubm\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitaly","family":"Margulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A.","family":"Karam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Roupr\u00eat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Seitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre I.","family":"Karakiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabela W.","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stenio C.","family":"Zequi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher G.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alon Z.","family":"Weizer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay D.","family":"Raman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mesut","family":"Remzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Rioux-Leclercq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solene","family":"Jacquet-Kammerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Bensalah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yair","family":"Lotan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Bachmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Rink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,29]]},"reference":[{"issue":"6","key":"1835_CR1","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.eururo.2013.03.032","volume":"63","author":"M Roupr\u00eat","year":"2013","unstructured":"Roupr\u00eat M, Babjuk M, Comp\u00e9rat E, Zigeuner R, Sylvester R, Burger M, Cowan N, B\u00f6hle A, Van Rhijn BW, Kaasinen E, Palou J, Shariat SF (2013) European guidelines on upper tract urothelial carcinomas: 2013 update. Eur Urol 63(6):1059\u20131071","journal-title":"Eur Urol"},{"issue":"1","key":"1835_CR2","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.eururo.2012.02.030","volume":"62","author":"G Lughezzani","year":"2012","unstructured":"Lughezzani G, Burger M, Margulis V, Matin SF, Novara G, Roupret M, Shariat SF, Wood CG, Zigeuner R (2012) Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature. Eur Urol 62(1):100\u2013114","journal-title":"Eur Urol"},{"issue":"1","key":"1835_CR3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00345-012-0946-6","volume":"31","author":"DR Yates","year":"2013","unstructured":"Yates DR, Catto JW (2013) Distinct patterns and behaviour of urothelial carcinoma with respect to anatomical location: how molecular biomarkers can augment clinico-pathological predictors in upper urinary tract tumours. World J Urol 31(1):21\u201329","journal-title":"World J Urol"},{"issue":"4","key":"1835_CR4","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.juro.2012.05.079","volume":"189","author":"DA Green","year":"2013","unstructured":"Green DA, Rink M, Xylinas E, Matin SF, Stenzl A, Roupret M, Karakiewicz PI, Scherr DS, Shariat SF (2013) Urothelial carcinoma of the bladder and the upper tract: disparate twins. J Urol 189(4):1214\u20131221","journal-title":"J Urol"},{"issue":"23","key":"1835_CR5","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1007\/s00018-008-8281-1","volume":"65","author":"F Roy Van","year":"2008","unstructured":"Van Roy F, Berx G (2008) The cell\u2013cell adhesion molecule E-cadherin. Cell Mol Life Sci 65(23):3756\u20133788","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"1835_CR6","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","volume":"133","author":"SA Mani","year":"2008","unstructured":"Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J, Weinberg RA (2008) The epithelial\u2013mesenchymal transition generates cells with properties of stem cells. Cell 133(4):704\u2013715","journal-title":"Cell"},{"issue":"6","key":"1835_CR7","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1158\/1078-0432.CCR-06-2330","volume":"13","author":"E Baumgart","year":"2007","unstructured":"Baumgart E, Cohen MS, Silva Neto B, Jacobs MA, Wotkowicz C, Rieger-Christ KM, Biolo A, Zeheb R, Loda M, Libertino JA, Summerhayes IC (2007) Identification and prognostic significance of an epithelial\u2013mesenchymal transition expression profile in human bladder tumors. Clin Cancer Res 13(6):1685\u20131694","journal-title":"Clin Cancer Res"},{"issue":"1","key":"1835_CR8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1309\/DKCLN4K2RK0V87YG","volume":"125","author":"A Clairotte","year":"2006","unstructured":"Clairotte A, Lascombe I, Fauconnet S, Mauny F, F\u00e9lix S, Algros MP, Bittard H, Kantelip B (2006) Expression of E-cadherin and \u03b1-, \u03b2-, \u03b3-catenins in patients with bladder cancer identification of \u03b3-catenin as a new prognostic marker of neoplastic progression in T1 superficial urothelial tumors. Am J Clin Pathol 125(1):119\u2013126","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"1835_CR9","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/S0022-5347(05)66330-6","volume":"165","author":"RR Byrne","year":"2001","unstructured":"Byrne RR, Shariat SF, Brown R, Kattan MW, Morton RA, Wheeler TM, Lerner SP (2001) E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term follow-up. J Urol 165(5):1473\u20131479","journal-title":"J Urol"},{"issue":"4","key":"1835_CR10","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/(SICI)1097-0215(19970822)74:4<446::AID-IJC15>3.0.CO;2-7","volume":"74","author":"K Nakanishi","year":"1997","unstructured":"Nakanishi K, Kawai T, Torikata C, Aurues T, Ikeda T (1997) E-cadherin expression in upper-urinary-tract carcinoma. Int J Cancer 74(4):446\u2013449","journal-title":"Int J Cancer"},{"issue":"6","key":"1835_CR11","doi-asserted-by":"crossref","first-page":"1443-e7","DOI":"10.1016\/j.urology.2011.07.1388","volume":"78","author":"M Muramaki","year":"2011","unstructured":"Muramaki M, Miyake H, Terakawa T, Kusuda Y, Fujisawa M (2011) Expression profile of E-cadherin and N-cadherin in urothelial carcinoma of the upper urinary tract is associated with disease recurrence in patients undergoing nephroureterectomy. Urology 78(6):1443-e7","journal-title":"Urology"},{"issue":"23","key":"1835_CR12","doi-asserted-by":"crossref","first-page":"5814","DOI":"10.1158\/1078-0432.CCR-10-0230","volume":"16","author":"T Kosaka","year":"2010","unstructured":"Kosaka T, Kikuchi E, Mikami S, Miyajima A, Shirotake S, Ishida M, Okada Y, Oya M (2010) Expression of snail in upper urinary tract urothelial carcinoma: prognostic significance and implications for tumor invasion. Clin Cancer Res 16(23):5814\u20135823","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1835_CR13","doi-asserted-by":"crossref","first-page":"513-e7","DOI":"10.1016\/j.urology.2010.03.070","volume":"76","author":"HG Jeon","year":"2010","unstructured":"Jeon HG, Jeong IG, Bae J, Lee JW, Won JK, Paik JH, Kim HH, Lee SE, Lee E (2010) Expression of Ki-67 and COX-2 in patients with upper urinary tract urothelial carcinoma. Urology 76(2):513-e7","journal-title":"Urology"},{"issue":"5","key":"1835_CR14","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.eururo.2005.07.005","volume":"48","author":"G Fromont","year":"2005","unstructured":"Fromont G, Roupr\u00eat M, Amira N, Sibony M, Vallancien G, Validire P, Cussenot O (2005) Tissue microarray analysis of the prognostic value of E-cadherin, Ki67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma. Eur Urol 48(5):764\u2013770","journal-title":"Eur Urol"},{"issue":"4","key":"1835_CR15","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1590\/S1677-55382012000400005","volume":"38","author":"ST Reis","year":"2012","unstructured":"Reis ST, Leite KR, Mosconi Neto A, Pontes J\u00fanior J, Viana NI, Antunes AA, Dall\u2019Oglio MF, Srougi M (2012) Immune expression of E-cadherin and \u03b1, \u03b2 and \u03b3-catenin adhesion molecules and prognosis for upper urinary tract urothelial carcinomas. Int Braz J Urol 38(4):466\u2013473","journal-title":"Int Braz J Urol"},{"key":"1835_CR16","doi-asserted-by":"crossref","unstructured":"Mathieu R, Klatte T, Margulis V, Karam JA, Roupr\u00eat M, Seitz C, Karakiewicz PI, Fajkovic H, Wood CG, Weizer AZ, Raman JD, Remzi M, Rioux-Leclercq N, Haitel A, Bensalah K, Lotan Y, Rink M, Kluth LA, Scherr DS, Robinson BD, Shariat SF (2015) Survivin is not an independent prognostic factor for patients with upper tract urothelial carcinoma: a multi-institutional study. Urol Oncol 33(11):495.e15\u201322","DOI":"10.1016\/j.urolonc.2015.06.016"},{"issue":"3","key":"1835_CR17","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1464-410X.2008.08003.x","volume":"103","author":"M Remzi","year":"2009","unstructured":"Remzi M, Haitel A, Margulis V, Karakiewizc P, Montorsi F, Kikuchi E, Zigeuner R, Weizer A, Bolenz C, Bensalah K, Suardi N, Raman JD, Lotan Y, Waldert M, Ng CK, Fern\u00e1ndez M, Koppie TM, Str\u00f6bel P, Kabbani W, Murai M, Langner C, Roscigno M, Wheat J, Guo CC, Wood CG, Shariat SF (2009) Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients. BJU Int 103(3):307\u2013311","journal-title":"BJU Int"},{"issue":"10","key":"1835_CR18","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/j.1464-410X.2010.09217.x","volume":"105","author":"SF Shariat","year":"2010","unstructured":"Shariat SF, Svatek RS, Tilki D, Skinner E, Karakiewicz PI, Capitanio U, Bastian PJ, Volkmer BG, Kassouf W, Novara G, Fritsche HM, Izawa JI, Ficarra V, Lerner SP, Sagalowsky AI, Schoenberg MP, Kamat AM, Dinney CP, Lotan Y, Marberger MJ, Fradet Y (2010) International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy. BJU Int 105(10):1402\u20131412","journal-title":"BJU Int"},{"issue":"2","key":"1835_CR19","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.eururo.2011.09.017","volume":"61","author":"TF Chromecki","year":"2012","unstructured":"Chromecki TF, Cha EK, Fajkovic H, Margulis V, Novara G, Scherr DS, Lotan Y, Raman JD, Kassouf W, Bensalah K, Weizer A, Kikuchi E, Roscigno M, Remzi M, Matsumoto K, Walton TJ, Pycha A, Ficarra V, Karakiewicz PI, Zigeuner R, Pummer K, Shariat SF (2012) The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy. Eur Urol 61(2):245\u2013253","journal-title":"Eur Urol"},{"issue":"4","key":"1835_CR20","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.eururo.2009.11.035","volume":"57","author":"R Zigeuner","year":"2010","unstructured":"Zigeuner R, Shariat SF, Margulis V, Karakiewicz PI, Roscigno M, Weizer A, Kikuchi E, Remzi M, Raman JD, Bolenz C, Bensalah K, Capitanio U, Koppie TM, Kassouf W, Sircar K, Patard JJ, Fern\u00e1ndez MI, Wood CG, Montorsi F, Str\u00f6bel P, Wheat JC, Haitel A, Oya M, Guo CC, Ng C, Chade DC, Sagalowsky A, Langner C (2010) Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract. Eur Urol 57(4):575\u2013581","journal-title":"Eur Urol"},{"issue":"1","key":"1835_CR21","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0090-4295(00)00892-X","volume":"57","author":"SF Shariat","year":"2001","unstructured":"Shariat SF, Pahlavan S, Baseman AG, Brown RM, Green AE, Wheeler TM, Lerner SP (2001) E-cadherin expression predicts clinical outcome in carcinoma in situ of the urinary bladder. Urology 57(1):60\u201365","journal-title":"Urology"},{"issue":"4","key":"1835_CR22","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.eururo.2011.12.055","volume":"61","author":"M Rink","year":"2012","unstructured":"Rink M, Fajkovic H, Cha EK, Gupta A, Karakiewicz PI, Chun FK, Lotan F, Shariat SF (2012) Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma. Eur Urol 61(4):854\u2013855","journal-title":"Eur Urol"},{"issue":"1","key":"1835_CR23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1083\/jcb.113.1.173","volume":"113","author":"UH Frixen","year":"1991","unstructured":"Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, L\u00f6chner D, Birchmeier W (1991) E-cadherin-mediated cell\u2013cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113(1):173\u2013185","journal-title":"J Cell Biol"},{"issue":"2","key":"1835_CR24","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/path.2346","volume":"215","author":"RT Bryan","year":"2008","unstructured":"Bryan RT, Atherfold PA, Yeo Y, Jones LJ, Harrison RF, Wallace DMA, Jankowski JA (2008) Cadherin switching dictates the biology of transitional cell carcinoma of the bladder: ex vivo and in vitro studies. J Pathol 215(2):184\u2013194","journal-title":"J Pathol"},{"issue":"4","key":"1835_CR25","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s11255-006-9159-5","volume":"39","author":"F Erdemir","year":"2007","unstructured":"Erdemir F, Ozcan F, K\u0131l\u0131caslan I, Parlaktas BS, Uluocak N, Gokce O (2007) The relationship between the expression of E-cadherin and tumor recurrence and progression in high-grade stage T1 bladder urothelial carcinoma. Int Urol Nephrol 39(4):1031\u20131037","journal-title":"Int Urol Nephrol"},{"issue":"6","key":"1835_CR26","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00345-011-0819-4","volume":"30","author":"B Han","year":"2012","unstructured":"Han B, Cui D, Jing Y, Hong Y, Xia S (2012) Estrogen receptor \u03b2 (ER\u03b2) is a novel prognostic marker of recurrence survival in non-muscle-invasive bladder cancer potentially by inhibiting cadherin switch. World J Urol 30(6):861\u2013867","journal-title":"World J Urol"},{"issue":"9","key":"1835_CR27","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.1442-2042.2011.02793.x","volume":"18","author":"X Hu","year":"2011","unstructured":"Hu X, Ruan Y, Cheng F, Yu W, Zhang X, Larr\u00e9 S (2011) p130Cas, E-cadherin and \u03b2-catenin in human transitional cell carcinoma of the bladder: expression and clinicopathological significance. Int J Urol 18(9):630\u2013637","journal-title":"Int J Urol"},{"issue":"8","key":"1835_CR28","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/nrurol.2011.96","volume":"8","author":"TF Chromecki","year":"2011","unstructured":"Chromecki TF, Bensalah K, Remzi M, Verhoest G, Cha EK, Scherr DS, Novara G, Karakiewicz PI, Shariat SF (2011) Prognostic factors for upper urinary tract urothelial carcinoma. Nat Rev Urol 8(8):440\u2013447","journal-title":"Nat Rev Urol"},{"issue":"4","key":"1835_CR29","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00345-011-0645-8","volume":"29","author":"W Otto","year":"2011","unstructured":"Otto W, Shariat SF, Fritsche HM, Gupta A, Matsumoto K, Kassouf W, Martignoni G, Walton TJ, Tritschler S, Baba S, Bastian PJ, Mart\u00ednez-Salamanca JI, Seitz C, Pycha A, Burger M, Karakiewicz PI, Ficarra V, Novara G (2011) Concomitant carcinoma in situ as an independent prognostic parameter for recurrence and survival in upper tract urothelial carcinoma: a multicenter analysis of 772 patients. World J Urol 29(4):487\u2013494","journal-title":"World J Urol"},{"issue":"4","key":"1835_CR30","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.eururo.2012.01.021","volume":"61","author":"EK Cha","year":"2012","unstructured":"Cha EK, Shariat SF, Kormaksson M, Novara G, Chromecki TF, Scherr DS, Lotan Y, Raman JD, Kassouf W, Zigeuner R, Remzi M, Bensalah K, Weizer A, Kikuchi E, Bolenz C, Roscigno M, Koppie TM, Ng CK, Fritsche HM, Matsumoto K, Walton TJ, Ehdaie B, Tritschler S, Fajkovic H, Mart\u00ednez-Salamanca JI, Pycha A, Langner C, Ficarra V, Patard JJ, Montorsi F, Wood CG, Karakiewicz PI, Margulis V (2012) Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma. Eur Urol 61(4):818\u2013825","journal-title":"Eur Urol"},{"issue":"2","key":"1835_CR31","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.juro.2010.04.016","volume":"184","author":"RT Bryan","year":"2010","unstructured":"Bryan RT, Tselepis C (2010) Cadherin switching and bladder cancer. J Urol 184(2):423\u2013431","journal-title":"J Urol"},{"issue":"9","key":"1835_CR32","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1158\/1078-0432.CCR-05-2387","volume":"12","author":"I Lascombe","year":"2006","unstructured":"Lascombe I, Clairotte A, Fauconnet S, Bernardini S, Wallerand H, Kantelip B, Bittard H (2006) N-cadherin as a novel prognostic marker of progression in superficial urothelial tumors. Clin Cancer Res 12(9):2780\u20132787","journal-title":"Clin Cancer Res"},{"issue":"6","key":"1835_CR33","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.eururo.2007.09.036","volume":"52","author":"K Bensalah","year":"2007","unstructured":"Bensalah K, Montorsi F, Shariat SF (2007) Challenges of cancer biomarker profiling. Eur Urol 52(6):1601\u20131609","journal-title":"Eur Urol"},{"issue":"2","key":"1835_CR34","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S1470-2045(07)70002-5","volume":"8","author":"JA Karam","year":"2007","unstructured":"Karam JA, Lotan Y, Karakiewicz PI et al (2007) Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy. Lancet Oncol 8(2):128\u2013136","journal-title":"Lancet Oncol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-016-1835-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-016-1835-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-016-1835-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-016-1835-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T03:16:05Z","timestamp":1718507765000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-016-1835-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,29]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["1835"],"URL":"https:\/\/doi.org\/10.1007\/s00345-016-1835-1","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,29]]}}}